CC-4047 (pomalidomide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CC-4047 (pomalidomide), covering 2013-04-17 to 2013-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide [Phase 1, Phase 2]